|
Neonatal Intensive Care Drug Manual
|
| bet | 510/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Dosage / Interval
|
Cardiac conditions and hypertension: Commence at 0.5–1 mg/kg/dose* 8 hourly and increase to 1–2 mg/kg/dose 8 hourly once dose tolerated.
*For infants with comorbidities that are likely to lead to hypoglycaemia (e.g. hyperinsulinism/preterm/low weight) – commence at 0.5 mg/kg/dose 8 hourly and increase to 1–2 mg/kg/dose 8 hourly as tolerated.
Thyrotoxicosis: 1–2 mg/kg/day in 2–3 divided doses to be titrated to heart rate and in consultation with endocrinologist/cardiologist.
Phaeochromocytoma: See evidence review.
Retinopathy of prematurity: See evidence review.
|
Maximum daily dose
|
Hypertrophic cardiomyopathy – doses as high as 5 mg/kg/dose 8 hourly may be used.
|
Route
|
Oral
|
|
|
| |
